Wednesday, March 18, 2026

Tag: Samsung Biologics

Samsung Biologics Expands Global Reach: 280 Million USD Acquisition of US Bio-Manufacturing Facility

Samsung Biologics acquires a U.S. biopharmaceutical facility, enhancing its global CDMO capabilities and ensuring stable supply chains.

Samsung Biologics Secures Massive 1.3 Billion CMO Deal Amid U.S. Trade Tensions

Samsung Biologics secures a $1.3 billion CMO deal with a U.S. firm, enhancing its global growth amid economic challenges.